Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Resting-State fMRI in MS: General Concepts and Brief Overview of Its Application.
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Endocannabinoids and the Immune System in Health and Disease.
Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).
Multiple Roles for Nogo Receptor 1 in Visual System Plasticity.
Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis.
Brain radiation and possible presentation of multiple sclerosis.
[Multiple sclerosis: oral drugs].
Anxiety state affects information processing speed in patients with multiple sclerosis.
Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
B cells in MS and NMO: pathogenesis and therapy.
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea.
Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis.
Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men.
Induction of heat shock protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun.
Ureteral rupture from aberrant Foley catheter placement: A case report.
Errors in the Byline, Author Affiliations, and Author Contributions in: Long-term Follow-up of Acute Partial Transverse Myelitis.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Acquired Demyelinating and Other Autoimmune Disorders of the Central Nervous System in Children.
Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.

Pages